Opioids impair nivolumab outcomes: a retrospective propensity score analysis in non-small-cell lung cancer

Abstract

Patients with NSCLC receiving regular opioid administration at nivolumab treatment initiation had a worse nivolumab treatment outcome than patients without opioid use.